Asia Pacific Next-generation Sequencing Market worth $7.38 billion by 2030
The report "Asia Pacific Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030", is projected to reach USD 7.38 billion by 2030, up from USD 3.40 billion in 2025, with a significant CAGR of 16.7% during the forecast period of 2025 to 2030.
Browse 450 market data Tables and 40 Figures spread through 350 Pages and in-depth TOC on "Asia Pacific Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-next-generation-sequencing-market-58994317.html
Several factors are driving growth in the Asia Pacific next-generation sequencing market. Rising cancer incidence and greater focus on rare and inherited diseases are encouraging healthcare systems to adopt personalized medicine. Moreover, investment in sequencing technology, genomics programs, and research institutions in major Asia Pacific countries is being driven by both government bodies and the private sector. Additionally, the trend toward personalized treatment options is gaining popularity, boosting demand for NGS in cancer profiling, inherited diseases, reproductive health screening programs such as NIPT, and infectious diseases. The rising acceptance of multi-omics in laboratories, integrated clinical informatics, and automation-capable lab workflows in the Asia Pacific is leading to an increased adoption of high-throughput sequencing systems, reagents, and sequencing capacity.
The products segment accounted for the dominant share in 2024.
By offering, the market is segmented into products and services. In 2024, products led the market, supported by a growing installed base of sequencers across major hospitals, national reference laboratories, academic institutions, and biopharmaceutical R&D centres in the Asia Pacific. This has created steady, repeat demand for high-usage reagents, flow cells or cartridges, library prep kits, and target enrichment panels. These products remain essential for scaling oncology testing, sequencing rare diseases and inherited disorders, and whole-exome or whole-genome sequencing, with consistent quality, throughput, and turnaround times across the region.
The sequencing segment is estimated to be the largest and register the highest CAGR from 2025 to 2030 in the Asia Pacific NGS products market.
By workflow, the Asia Pacific next-generation sequencing products market is divided into sequencing, presequencing, and data analysis. The sequencing segment comprises core revenue drivers, including sequencing instruments, flow cells/cartridges, sequencing reagents, and run consumables. It leads because it directly determines data output, throughput, and per-sample cost, and it scales with rising test volumes across the region. Growth is supported by expanding NGS use in precision oncology (tumor profiling, MRD, liquid biopsy), rare disease and inherited disorder testing, reproductive health screening, and infectious disease surveillance. In parallel, the demand for sequencing in microbial genomics, public health programs, and agricultural genomics is increasing in the Asia Pacific countries, further strengthening the uptake of high-throughput sequencing products.
China is likely to be the fastest-growing country in the Asia Pacific NGS market during the forecast period.
By country, the European NGS market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. China is emerging as a key growth market, supported by rising public and private investment in precision medicine and genomics, a strong network of large hospitals and reference laboratories, and the rapid scale-up of clinical sequencing capacity. Adoption is accelerating across oncology profiling, rare and inherited disease testing, reproductive health screening, and infectious disease surveillance, driving higher test volumes and repeat demand for NGS products and services.
Prominent players operating in the Asia Pacific NGS market include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Wuxi Biologics (China), and Takara Bio (Japan), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Next-generation Sequencing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
